Judy Garber, MD, Oncology, Boston, MA, Brigham and Women's Hospital

JudyEllenGarberMD

Oncology Boston, MA

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Dr. Garber is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Garber's full profile

Already have an account?

Education & Training

  • Dana-Farber Cancer InstituteFellowship, Medical Oncology, 1985 - 1989
  • Boston VA Healthcare SystemResidency, Internal Medicine, 1984 - 1985
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1981 - 1984
  • Yale University School of Medicine
    Yale University School of MedicineClass of 1981

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1984 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Boston Magazine Castle Connolly, 2008-2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adult...
    Judy Garber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Advances in Germline Genetics: What Surgeons Need to Know 
    Boston, MA - 10/28/2014

Press Mentions

  • City of Hope to Lead National Research Aimed at Improving testing/treatment for Devastating Cancer-Causing Syndrome
    City of Hope to Lead National Research Aimed at Improving testing/treatment for Devastating Cancer-Causing SyndromeNovember 22nd, 2019
  • Cancer Patient Says Question Could Save Lives: 'Do You Have Eastern European Jewish Ancestry?'
    Cancer Patient Says Question Could Save Lives: 'Do You Have Eastern European Jewish Ancestry?'August 21st, 2019
  • Dr. Henry Lynch, 91, Dies; Found Hereditary Link in Cancer
    Dr. Henry Lynch, 91, Dies; Found Hereditary Link in CancerJune 13th, 2019
  • Join now to see all

Grant Support

  • Discovery, Biology And Risk Of Inherited Variants In Breast CancerNational Cancer Institute2010–2011
  • Epidemiology Of Syndromic GI Stromal TumorsNational Cancer Institute2007–2010
  • Pilot Study Of Aromatase InhibitorsNational Center For Research Resources2004–2008
  • Process &Outcomes Of Brcal/2 Clinical TestingNational Human Genome Research Institute2002–2003
  • Breast Cancer Prevention In Hodgkins DiseaseNational Cancer Institute2001–2002
  • Plasma Estrogens In Breast Cancer Risk And PreventionNational Cancer Institute2000–2002
  • Process &Outcomes Of BRCA1/2 Clinical TestingNational Human Genome Research Institute2001
  • Randomized Study--Brca1/2 Genetic V Consent CounselingNational Human Genome Research Institute1997–2001
  • Treatment Of Depression In Parents--Impact On ChildrenNational Institute Of Mental Health1998
  • Predictive Testing Program For P53 Mutations In LfsNational Human Genome Research Institute1994–1996
  • Dissemination Of A Brcal Predisposition Testing ProgramNational Human Genome Research Institute1994–1996
  • Development Of Depression In Children And AdolescentsNational Institute Of Mental Health1991–1995

Professional Memberships

Hospital Affiliations